I.M.Sechenov First Moscow State Medical University Russia
Sergey Suchkov graduated from Astrakhan State Medical University and awarded with MD, then in 1985 maintained his PhD at the I.M. Sechenov Moscow Medical Academy and in 2001, maintained his Doctorship Degree at the Nat Inst of Immunology, Russia. From 1987 through 1989, he was a senior Researcher, Kolt-zov Inst of Developmental Biology. From 1989 through 1995, he was a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI.DrSuchkov has been trained at: NIH; Wills Eye Hospital, PA, USA; Univ of Florida in Gainesville; UCSF, S-F, CA, USA; Johns Hopkins University, Baltimore, MD, USA. He was an Exe Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is a Chair, Dept for Personalized and Translational Medicine, I.M.Sechenov First Moscow State Medical University. He is a member of the: New York Academy of Sciences, USA; American Chemical Society (ACS), USA; American Heart Association (AHA), USA; EPMA (European Association for Pre-dictive, Preventive and Personalized Medicine), Brussels, EU; ARVO (American Association for Research in Vision and Ophthalmology); ISER (International Society for Eye Research); PMC (Personalized Medicine Coalition), Washington, USA.
Giulio Tarro graduated from Medicine School, Naples University (1962). Research Associate, Division of
Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics,
College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples
University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories,
(2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman
Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO,
Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia,
recipient of the Sbarro Health Research Organization lifetime achievement award (2010). President
Foundation de Beaumont Bonelli for Cancer Research. His basic researches have been concerned with
antigens induced early during the replication cycle of human herpesviruses. Another study has involved the
identification, isolation and characterization of specific virus-induced tumour antigens, which were the
"finger-prints" left behind in human cancer.Achievements include patents in field; discovery of Respiratory
Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55
kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.
Who’s Who in America
Who’s Who in the World
TARRO, GIULlO, virologist; b. Messina, Italy, July 9, 1938; s. Emanuele and Emanuela (Iannello) Tarro; 1
adopted child, Giuseppe. MD, U. Naples, 1962, postgrad. in nervous diseases, 1968, PhD in Virology, 1971;
postgrad. in med. and bioI. scis., Roman Acad., 1979; degree in medicine (hon.), U. Pro Deo, Albany, NY,
1989; degree in immunology (hon.), St Theodora Acad., NY, 1991; degree in bioethics (hon.), Constantinian
U., Cranston, RI, 1996; MSc in Biomed. Techs. (hon.), ASAM U., Rome, 2008; degree in Social Scis. (hon.),
Bonake U., Abidjan, Cote d'Ivoire, 2010. Asst. in med. pathology Naples U., Italy, 1964-66; rsch. assoc. divsn.
virology and cancer rsch. Children's Hosp., Cin., 1965-68; asst. prof. rsch. pediat, U. Cin. Coil. Medicine,
1968-69; rsch. fellow Nat. Rsch. COUll., Naples, 1966-74, rsch. chief, 1974; prof. oncologic virology Call.
Medicine U. Naples, 1971-85, prof. microbiology and immunology Sch. Specialization, 1972-2006; chief
divsn. virology D. Cotugno Hasp. Infectious Diseases, Naples, 1973-2006, pres. ethic com., 1998-2007, head
dept. diagnostic labs., 2003-06, emeritus, 2006-. Sr. scientist Nat. Cancer Inst. Frederick Ctr., Md., 1973;
project dir. Nat Cancer Inst., Bethesda, Md., 1971-75; edn. min. rep. Zool. Sta., Naples, 1975-79; cons.
Italian Pharmacotherapic Inst., Rome, 1980-98, med. dir., 2006-07; nat. com. on bioethics, 1995-98; ethics
com. Basilicata Oncologic Hosp., 2005-13; pres. De Beaumont Bonelli Found. Cancer Rsch., Naples, 1978-,
European Group Econ. Interest, Rsch, and Devel., Naples, 2003-07, Campania Tech. and Ecology Ctr., 2004-
12; dean faculty natural and phys. sets. Nobile Accademia di Santa Teodora Imperatrice, 1993-2003; dept.
head medicine Naples People U., 2000-05; sci. coord. extracorporeal hyperthermia in HCV patients First
Circle Med., Mpls., 2000-03; vice chmn., gen. sec. sci. adv. bd. Unihart Biotech Pharm., London, 2005-07;
chmn. com. on biotechs. and virusphere World Acad. Biomed. Techs., UNESCO, Paris, 2007-; adj. prof. dept
biology Temple U. Call. Sci. and Tech., Phila., 2007-, pres. sci. com. Moravia U. Gonzaga Inst. Naples, 2008-
09, pres. Norman Acad. Rome, 2009-. Nat com. On health, 2013. Author: Virologia Oncologica, 1979,
Patologia dell'AIDS, 1991, Can iI Cancro si PUG Vivere, 1992, AIDS Cosa Possiamo Fare Cosa Dobbiamo
Sapere, 1994, Pocket File Research Collection, 1997, 6th edit., 2003, To Prevent Is To Win, 1998, Bioethics
and Culture of Prevention, 2001, Health Without Borders, 2004, 5th edit., 2012, Safety No Limits, 2008,
Campania Land of Poisons, 2012, Medicine is Life; 2013; editor-in- chief: Internal. Jour. Clin. Investigation,
2000-10, Cotugno News, 2003-09, Fratres, 2004-; Journal of Vaccine and Development, 2015 -; contbr.
more than 490 articles to profl. jours.Pres. Sci. Cultural Com., Torre Annunziata, Italy, 1984, Tumor
Prevention Assn., Rome, 1984; mem acad senate Constantinian U., Providence, 1990, U. Pro Deo, NY, 1994;
hon. acad U. Sancti Cyrilli, Valletta, Malta, 2001; mem UNESCO-Hebrew U. Jerusalem Internat. Sch.
Molecular Biology and Microbiology, hon. rector Ruggero II U., Fla., 2003, pres., 2013-. Maj. Italian Navy,
1982-84, Lt. col., 1993-95, mem UN Internat. Computing Sci. Acad., 1997, mem Lions Found., 1990-91
Decorated comdr, Nat. Order of Merit, Star of Europe, knight grand cross Sovereign Constantinian Order St,
George, gt officer Italian Republic; recipient Internal. Lenghi award Lincei Acad., 1969, Gold Microscope
award Italian Health Min., 1973, Knights of Humanity award Internat. Register of Chivalry, Malta, 1978,
Gold medal of culture Pres. Italian Republic, 1975, Culture award, 1985,1st prize in biomed. rsch., Italian
Acad. Arts and Scis., 1987, Castello di Pietrarossa award, Italy, 1991, Gold Cesare award Padova, 1991, Gold
Little Horse, Transnat. European Fedn., Rome 1996, King Manfredi award and Silverplate Pres. Italian rep.
Manfredonia, 1999, Equestris Ordinis S. Sepulcri of Ierusalem, Rome, 1999, Gold medal of health Pres.
Italian Republic, 1999, Saint Catherin award, Siena, 2003, Sorrento in the World award, 2004, Medal of
Culture Ministry, 2005, Knight of Solidarity Internat. award Norman Acad .• Rome, 2006, hon. pres. 2009-,
st. Pia for Peace award City of Fiuggi, 2006, Tables of Law award Internal. Assn. Cath. Apostleship, Naples.
2006, 32nd -Casentino lnternat. award in medicine Poppi-Arezzo, 2007, Grand Cross-Internat. Acad. State
Wyo., 2008, award Pres. Italian Rep, Silver medal, 2004, 2008, Lifetime Achievement award, Sbarro Health
Rsch. Orgn.Phila., 2009, Nat. award for solidarity Fratres St. Giovanni La Punta, 2010, Global Edn. Sanremo
award, 2011. Internal. Peace award, 2011, Grand Prix Solidarite Dem. Rep. Congo, 2010, Gold medal,
Norman Acad., Rome, Internat, prize, Le Muse, Florence, 2012, Gold medal for 50 Yrs. MD, Rilancio Italia
award, Rome, 2013, Knight Grand Cross Cernetic Imperial Order, Belgrade, 2013. Fellow: AAAS; mem.:
Internat. Soc. Neurovirology, Tu es Petrus (Vatican City) (sci. com. mem.), Royal House Aranan (Philippine)
(Gold medal 2012), Am. Chern. Soc., European Soc. Clin. Virology, NY Acad. Scis., Nat. Order Journalists,
AIDS Sac. Asia and the Pacific, Assn. Res. Prevention of Cancer (sci. com. 1995), Italian Assn. Viral Study and
Rsch, (pres. 1995-2008, hon. pres. 2009-), Italian Soc. Immuno-Oncology (v.p. 1975-, pres. 1990-2008),
Internat. League Drs. for Abolition of Vivisection (pres. 1992-2012), Internat. Assn. Leukemias, Am. Assn.
Cancer Rsch., Am. Soc. Microbiology (people to people amb to South Africa 2010), Acad. History Sanitary
Art (hon.), Rotary, Lions (pres. Pompei chpt. 1987-89, pres. com. fight cancer 1989-90, vice gov. dist. 1991-
92, pres. com. fight cancer 1992-94, pres. com. sci. and life 1994-95, pres. com. fight drug addiction and
AIDS 1995-97. pres. com. transplant and donations 1998-99, pres. com. oncology 2000-02, pres. com. on
stem cells 2002-03, dist. dir. operative area ethics and social solidarity 2003-04, pres. Pompei chpt. 2004-
06, dist. dir. operative area health and rsch. 2006-14, dist. dir. rare diseases 2014-15, LISC Internat dir.
2012-14, Melvin Jones fellow 1993,2004,2008,2010, 1995). Roman Catholic. Achievments include patents in
fieldof first link-at-viruses to human cervical cancer; discovery ofRSV virus in infant deaths in Naples and of
tumor liberated protein as a tumorassociated antigen, 55 kilodalton protein overexpressed in lung tumors
and other epithelial adenocarcinomas. Flu virus expert 2015. Home Via Posillipo 286 80123
Naples NA Italy
Dr. Michael J. Gonzalez is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the University of Western States And EDP University. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 200 scientific publications. He serves as a member on multiple scientific Editorial Boards. He has served as consultant for several companies where he has been responsible for designing formulations of nutritional supplements and pharmaceutical products. He has also been a consultant for The Center for the Improvement of Human Functioning (now Riordan Clinic), in Wichita, Kansas. He has obtained several research awards for his work on Nutrition and Cancer. He is currently Co- Director of RECNAC II project, and Research Director of the InBioMed Project Initiative. Dr. Gonzalez also serves as a nutrition consultant to the Puerto Rican Basketball National Team and is part of the Medical Commission of the Puerto Rican Basketball Federation. He was part of the Medical Staff of the Vaqueros de Bayamon professional basketball team in Purto Rico. He is in a part time clinical practice with Dr. Miguel J Berdiel in Ponce, PR. In December 2013,Dr. Gonzalez was exalted as Distinguished Ponceño in Medicine. In 2015 he was selected as member to the prestigious Puerto Rican Academy of Arts and Sciences and to the Iberoamerican Academy of Culture and Sciences.
Doctor González is one of the founders of InBioMed, leaders in the development of non-toxic chemotherapy treatments for cancer. The findings of their work with Intravenous Vitamin C as an anti-cancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for treatment of terminal cancer patients in 2005, and also published in 2005 the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus C. Pauling. They have brought many new concepts into the scientific field, such as the Bioenergetic theory of carcinogenesis, the systemic saturation phenomenon of intravenous vitamin C, the metabolic correction concept for disease treatment and prevention. Dr. Gonzalez was inducted to the International Hall of fame of Orthomolecular Medicine April, 2016. He is one of the first hispanoamerican and Puerto Rican to be inducted to the International Hall of fame of Orthomolecular Medicine.
Books: “I Have Cancer What Should I do: The Orthomolecular Guide to Cancer Management” provides evidence based recommendations for an integrative approach for those dealing with cancer and seeking to improve quality of life and survival. In 2014 ” New Insights Vitamin C and Cancer” a book on the scientific evidence on Vitamin C as an anticancer agent for Springer-Larger. Dr. Gonzalez is actually finishing a book on Metabolic Correction and Diabetes and writing a chapter on metabolic correction and disease for a Functional medicine textbook.
Dr. Seema Habib Isa has completed her Ph.D. at the age of 33 years from the Swami Ramanand Teerth Marathwada University, Nanded, Maharashtra, India. Awarded with Honorary Degree of Doctor of Science for outstanding Scientific Contribution in Chemisty by International Agency for standards and Ratings. Awarded the Prestigious Adarsh Saraswati Rashtriya Puraskar by Global Management Council of Glacier Journal Research Foundation, Ahmadabad, Gujarat. She is a Fellow of the International Association of the Science Impact (F.I.A.S.I), published more than 47 papers in reputed journals and has been serving as an Editorial Board Member of the National Journals and International Journals. Her area of research interest is Organic Synthesis and its applications to Inorganic Synthesis.
The London BioScience Innovation Centre United Kingdom
The London BioScience Innovation Centre United Kingdom
Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement,include BBC, ITV, WSJ, CNN, and many more.Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.
Yavuz Selim Sılay
Co-Founder & CEO of MAIN(MaQasid Angel Investors Network) Turkey
Co-Founder & CEO of MAIN(MaQasid Angel Investors Network) Turkey
Dr. Yavuz Selim Sılay is the Co-Founder & CEO of MAIN(MaQasid Angel Investors Network) & chairman of Istanbul Consulting Group. MAIN(MaQasid Angel Investor Network) is one the fast growing global angel investment groups . ICG(Istanbul Consulting Group) which was founded in 2013 and provided guidance to the Turkish ministry of health as part of a World Bank project.Yavuz is currently the Co-Founder of BioCube İstanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of Archem Diagnostics. He previously managed the largest distributor of Siemens Healthcare in Turkey managing 250 employees and director of Avcılar Hospital R&D Center, Chief Medical Officer of Lifematrix GmbH. Previously he worked as the Market Access & Health Policy Director for AIFD in Turkey.
Yavuz previously worked as the Vice President of Ipsen pharmaceutical and Director of Teva pharmaceutical in USA managing large clinical trials as well as Investigator Initiated Trials and developing relationships with Key Opinion Leaders. Previously, Yavuz was the Associate Director at KV Pharmaceuticals and Director in Clinical Development department at Forest Laboratories
Yavuz earned his MD from the Faculty of Medicine, University of Ankara in Ankara, Turkey. He completed a clinical internship at Baylor College of Medicine in Houston, followed by continued research training at The University of Texas MD Anderson Cancer Center in Houston. He recently completed his Executive MBA at the Olin Business School at Washington University in St. Louis. Yavuz currently resides with his wife Dr. Kamile Sılay and their two daughters and one son in Ankara,Turkey.
Dr Tarek Mohamed Kamal Mohamed Metawie, Professor of Biochemistry, Faculty of Pharmacy, Cairo University. Egyptian, date of birth 6/3/1955. Ph.D. in Pharmaceutical Sciences, 1984; M.Sc. in Pharmaceutical Sciences, 1979; B.Sc. in Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, 1976.
Instructor; 1976, Lecturer Assistant; 1980, Lecturer, 1984; Assistant Professor, 1989; Professor,1994; Head of the Department of Biochemistry, Faculty of Pharmacy, Cairo:- 2008-2014
As a Dean of SRM Pharmacy College, SRM University India, for the past 20 years.1996-
Served as a Principal with Vel’s College of Pharmacy, The Tamil Nadu Dr. MGR Medical
University, Chennai, India for four years.1992-1996
Lecturer at CLBM College of Pharmacy Chennai Tamil Nadu India 1990-1992.
First Assignment as Lecturer at JSS College of Pharmacy Ooty Tamil Nadu India 1988-
•Key responsibilities included program development and annual program funding allocation.
•Taught UG, PG grades in Pharmacy for 22 years.
•Currently as Dean cum Head of Department of Pharmaceutical Analysis, SRM College of
Pharmacy, SRM University- India. Website www.srmuniv.ac.in.
• Inspector for the Pharmacy Council of India, New Delhi – India.
• Inspector for the Tamil Nadu DR.M.G.R Medical University, Chennai – India.
Mohamed Eddouks is Professor at Moulay Ismail University, Faculty of Sciences and Techniques Errachidia, Morocco. He is a researcher in Physiology and Pharmacology with a Master Degree in Metabolic and Molecular Endocrinology from University of Paris 6, a specialized certificate in Endocrine Pharmacology from University of Paris 7 and PhD degrees in Physiology and Pharmacology from University of Liege, Belgium and Sidi Mohammed Ben Abdellah University, Fez, Morocco. After his post-doctoral fellowship at Department of Physiology, Faculty of Medicine of Montreal, Canada, he is working for the last 20 years on medicinal plants. His research focuses on ethnobiological as well as pharmacological issues in the use of Moroccan medicinal plants for the treatment of diabetes mellitus, obesity and hypertension. His contribution to this field includes four international books, 5 special issues in Evidence-Based Complementary and Alternative Medicine and more than 100 indexed peer-reviewed articles and 20 book chapters of international repute. He served as Guest Editor and Member of Editorial Board of several international journals. He has been honored with the first Prize of Scientific Research in 2008 by the Moroccan Association of Research and Development and the first Prize of the Federation of Arab Scientific Councils in 2016. He has been classified among the best third Moroccan researchers in the field of Life Sciences and Pharmaceutical Sciences by the National Center of Scientific Research and Technology, Morocco for his scientific contribution. He has been the founding Dean of Polydisciplinary Faculty of Errachidia from 2008 to 2012.
Stefania Galdiero earned her PhD in Chemistry in the field of peptides at the University of Naples ‘‘Federico II’’ in 1998. She carried out research activities at the Columbia University of New York in 1996-97. In 1999 she earned the position of lecturer in Inorganic Chemistry at the University of Naples and from 2012 to 2018 she has been Adjunct Professor at Loyola University Chicago. Since 2015 she is Associate Professor of Inorganic Chemistry. Recent research activities focus on antimicrobial peptides and mechanisms of drug intracellular delivery for cancer. Elucidating the principles that govern the protein/membrane interactions and understanding the molecular forces underlying peptide-peptide interactions within the lipid environment of the cell membrane are major goals. She is author of more than 100 publications in international scientific journals.
Ana Henriques Mota is doing her Ph.D. programme in Pharmaceutical Technology at Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal, under super vision of Professor Catarina Pinto Reis, Professor António José Almeida and Professor Elias Fattal. In 2015, she received the M.S. degree in Pharmaceutical Sciences from Universidade Lusófona de Humanidades e Tecnologias, Lisbon, Portugal. In 2014, she did a Research Internship at the Faculté de Pharmacie, Université de Lorraine, Nancy, France, under supervision of Professor Philippe Maincent. From 2016 to 2017, she was Assistant Professor in Pharmaceutical Technology at the School of Sciences and Health Technologies at Universidade Lusófona de Humanidades e Tecnologias, Lisbon, Portugal. She is author of four articles. Her research interests include nanotechnology, in vitro and in vivo assays.
Amer A. Taqa: Professor at Dental Basic Science,
College dentistry, Mosul University, Iraq. Have PhD
degree in Dental chemistry. He has published more 100
researches papers in national and international academic
journals and authored 22 books. His research interests
include dental chemistry, medical chemistry, and
inorganic chemistry. He is editorial member in more than
140 international journals. He Nominated as a member of
the organizing committees for a number of international
and local conferences
McConville earned his Ph.D. at the University of Strathclyde, Scotland in 2002 in the area of chronopharmaceutics. He moved to Austin, TX in 2002 as a post-doctoral fellow before being appointed to Assistant Professor. He joined the faculty at the University of New Mexico in June 2012 as an Associate Professor. His research interests include: nanotechnology, pulmonary targeting, and chronopharmaceutics. Dr. McConville is also an Adjunct Professor in the Department of Pharmaceutical Technology at the University of Bonn. Germany and has published more than 40 papers in the field of pharmaceutics.
Shereen Mashhour Assaf
Jordan University of Science and Technology Jordan
Mohsen Afouna working as a Professor and Chariman in Al-Azhar University, Egypt.Highly motivated scientist (teacher, researcher) with expertise in development of oral, topical, transdermal and sterile (ocular & parenteral) drug delivery systems. In addition to extensive experienced in development, physico- (chemical/-mechanical) and in vivo characterization of noano-pharmaceutical drug delivery systems. Outstanding teaching & research experience in pharmaceutical sciences, development and management of scientific research projects combined with fluency in English and Arabic. High experience regarding chirality, physical & clinical pharmacy, biopharmaceutics & pharmacokinetics. Excellent written and oral communication skills with supervisory and teaching experience. Author of several recent articles, review articles and chapter in textbooks. Driven pharmaceutical scientist, love to work in a dynamic teaching, research and development environment.
Ângela Pizarro is a deputy head pharmacist of a recognized Pharmacy Group in Portugal. Specializes in pharmacovigilance systems and regulatory affairs, is a PhD candidate in International Health: Policies and Health and Development in Diabetes. Since 2009 she has developed research at portuguese and international universities (Brazil, USA and Geneve) in the areas of pharmacovigilance of drug-interactions, e-health, telemedicine, artificial intelligence in diabetes and policy solutions for global health systems.
Hossam El Nazer
Professor of Photochemsitry/Photocatalysis
Photochemistry Department, Chemical Industries Research Division, National Research Centre,
Dokki, Giza, Egypt.
LIST of PUBLICATIONS
1. A. M. Baraka, H. H. Shaarawy, H. A. Hamed El Nazer, "Electrodeposition of rhodium metal over titanium substrates", Journal of Anti-Corrosion Methods and Materials, 49(4), (2002), UK.
2. A. M. Baraka, H. H. Shaarawy, H. A. Hamed El Nazer, "Electrodeposition of Platinum metal and Platinum-rhodium alloy over titanium substartes", Journal of Material Engineering and Performance, 12, 5, 2002, U. S. A.
3. A. M. Baraka, H. H. Shaarawy, S. S. Mahmoud, H. A. Hamed El Nazer, "Electrocatalytic oxidation of textile wastewater using Palladium\Titanium modified electrode", Journal of Tex. Polym. Sci. Technol., 6, 73, 2002. Egypt
4. H. H. Shaarawy, H. A. Hamed El Nazer, "Phenol degradation by electrogenerated Fenton's Reagent using Titanium\Rhodium modified electrode", The 8th International Conference on Portable Water Management Water Technologies, Aqua Tec., p. 44-58, Jan. 2003.
5. A. M. Baraka , A. A. Nada , H. H. Shaarawy,H. A. Hamed El Nazer, "Investigation of the optimum conditions for methanol electrocatalytic oxidation using Titanium/Rhodium thermally activated modified electrodes", Al Azhar University Engineering Journal Vol. 7, No. 1, 2004, 89-100. Egypt
6. Afaf A. Nada, M. Hany. Barakat, Hossam A. Hamed El Nazer, Nadia R. Mohamed, T. Nejat. Veziroglu, "Studies on the photocatalytic hydrogen production using suspended modified TiO2 photocatalysts", Int. J. Hydrogen Energy, 30, 687 (2005). USA.
7. A. A. Nada, M. H. Barakat, H. A. Hamed El Nazer, N. R. Mohamed, T. N. Veziroglu , "Photocatalytic production of hydrogen" , The International Hydrogen Energy Congress and Exhibition 2005 (IHEC-2005). Istanbul, Turkey.
8. A.A. Nada, H.A. Hamed El Nazer, M.H. Barakat, N.R. Mohamed, T.N. Veziroglu, Enhancement of photocatalytic hydrogen production rate using photosensitized TiO2/RuO2-MV2+, Int. J. Hydrogen energy, 33 ( 2008 ) 3264 – 3269.
9. Giovanni Palmisano, Vittorio Loddo, Hossam Hamed El Nazer,Sedat Yurdakal,Vincenzo Augugliaro, Rosaria Ciriminnab and Mario Pagliaro, Chemical Engineering Journal, Graphite-Supported TIO2 for 4-nitrophenol degradation in a photoelectrocatalytic reactor, Chemical Engineering Journal 155 (2009) 339–346.
10. V. Augugliaro, H.A. Hamed El Nazer, V. Loddo, A. Mele, G. Palmisano, L. Palmisano, S. Yurdakal,"Partial photocatalytic Oxidation of Glycerol in TiO2 Water Suspensions", CatalysisToday. 2010. 151, 21-28.
11. A. M. Khalil, H. A. Hamed El Nazer, M. M. Badr, A.A. Nada, "Efficient Preparation of Polymeric Based Hollow Spheres for Photocatalytic Degradation of Methylene Blue", Journal of Vinyl and Additive Technology,16 (2010) 272-273.
12. Rifaat A.Wahaab, Ahmed K.Moawad, Enas A.Taleb, Hanan S. Ibrahim and Hossam A. H. El-Nazer , "Combined Photocatalytic Oxidation and Chemical Coagulation for Cyanide and Heavy Metals Removal from Electroplating Wastewater" , World Applied Sciences Journal 8 (4): 462-469, 2010.
13. Hossam A. El-Nazer, Samira T. Rabie, Hesham A. EL Meleegy, Mahmoud A. Abdel-Ghaffar,Afaf A. Nada , “Photocatalytic Synthesis of 2-Hydroxyethyl methacrylate/Butyl acrylate (HEMA/BuA) Copolymer and its Metal Complexes” , Inorganic Chemistry: An Indian Journal 8(3), 88-96, (2013).
14. A. M. Khalil, H. A. Hamed El-Nazer, S. T Rabie, A.A. Nada, " Synthesis and evaluation of photoactive polyethylene terephthalate-gethylmethacrylate based on waste PET” Macromolecules An Indian Journal 9(4)131-139, (2013).
15. S. T. Rabie, H. A. El-Nazer, A. A. Nada, “Synthesis and Evaluation of Homopolymer and Terpolymer Based on Phenyl Salicylate as Photostabilizers for Rigid Polyvinylchloride”. Journal of Vinyl and Additive Technology,2015.
16. W. M. Darwish, M. H.. Abu Bieh, A. A. Nada, H. A. ELNazer, M.S.A. Abdel-Mottaleb. Spectrophotometric evaluation of photocatalytic activity of nanostructured N-TiO2 and N,F-TiO2 by oxidative degradation of phthalocyanine star polymer. Adv. in Nat. Appl. Sci., 9(12): 105-115, 2015.
17. M. Bellardita, H. A. El Nazer, V. Loddo, F. Parrino, A. M. Venezia, L. Palmisano, “Photoactivity Under Visible Light of Metal Loaded TiO2 Catalysts Prepared by Low Frequency Ultrasound Treatment, CatalysisToday.284(2017)92-99(2017).
18. S A Salman, A A Elnazer, H A El Nazer, "Integrated mass balance of some heavy metals fluxes in Yaakob village, south Sohag, Egypt", Int. J. Environ. Sci. Technol., (2016). doi:10.1007/s13762-016-1200-3.
19. A.A. Elnazer, H.A. El Nazer, S.A. Salman, Irrigation water quality assessment and a new approach to its treatment using photocatalytic technique: Case study Yaakob village, SW Sohag, Egypt, Journal of materials and Environmental Sciences 8 (1), 310-317.
20. John T Petroff II, Anh H Nguyen, Alex J Porter, Fraisher D Morales, Michael P Kennedy, David Weinstein, Hossam El Nazer, Ryan D McCulla, Enhanced photocatalytic dehalogenation of aryl halides by combined poly-p-phenylene (PPP) and TiO2 photocatalysts, Journal of Photochemistry and Photobiology A: Chemistry 335, 149-154(2017)
21. Hossam A El Nazer, Elzahraa A Elgohary, Samira T Rabie, Photostability, thermal and mechanical properties of poly (vinyl chloride)/novel acrylate terpolymer blend, Journal of Vinyl and Additive Technology, 2018
22. Samir T.Gaballah, Hossam A .El Nazer, Reham A.Abdel-MonemaMohamed, AzabEl-Liethy, Bahaa A.Hemdan, Samira T.Rabie, Synthesis of novel chitosan-PVC conjugates encompassing Ag nanoparticles as antibacterial polymers for biomedical applications International Journal of Biological Macromolecules Volume 121, January 2019, Pages 707-717
23. Yasser M. A. Mohamed, Hossam A. El Nazer, Eirik Johansson Solum, Practical synthesis of silyl-protected and functionalized propargylamines using nanostructured Ag/TiO2 and Pt/TiO2 as active recyclable catalysts, Chemical Papers,2018, pages 1-11.
24. Sherif S. Ragab Abdelrahman A. Badawy, Hossam A. El Nazer, A green approach to the synthesis of 2,3 diaminophenazine using a photocatalytic system of CdFe2O4/TiO2 nanoparticles, J Chin Chem Soc. 2019; 1–6.
Hossam A. El Nazer
D.Nagasamy Venkatesh is Assistant Professor at Department of Pharmaceutics, JSS College of Pharmacy, Udhagamandalam. India. Dr. D.Nagasamy Venkatesh is interested in developing certain nanobased drug delivery systems for antiviral and anticancer drugs. His research is also involved in developing sustained/controlled drug delivery systems for certain drugs and analytical and bio-analytical method development for drugs. He serves as a reviewer of more than 25 peer reviewed journals including AAPS, Carbohydrate polymer, Indian Journal of Pharmaceutical Sciences. He serves editorial board member for more than 20 international journals. Dr. D.Nagasamy Venkatesh has authored more than 50 peer-reviewed publications. He has received three awards for his presentations/publications in various international and national conferences.
I am Dr. Mojtaba Mafi M.D., Medical Doctor/ Physician, graduated from Tehran university, School of
Medicine with honor. I studied in neurosurgery ward and graduated with A score with thesis on
Meningioma Brain Tumor during 6 years.
With continuing my practice with special consideration on psychosomatic disorders, I completed
many post graduate courses on health psychology, addiction medicine, sexual disorders therapy
successfully. I passed many post graduate courses in Neuro, approved by Medical sciences
university. As well, I have been passed post graduate courses on Nutrition, Gastroenterology and
hepatology, Obesity treatment and diabetes approved by Tehran University of Medical sciences.
I successfully passed more than 10 programs with certificates and membership in Iranian Association
of Gastroenterology and Hepatology.
Having honor of working as associate of Iran Hepatitis Network and Gastroenterology and
Hepatology research center, Middle East Liver Diseases Center (MELD).
This strong study background enabled me to successfully earn certificates on 3 programs: Updates of
skin and treatment from Tehran university 2015 and course on skin care updates from Iranian
society of practitioners on 2016, and during 2 years, I had passed Beauty and Skin care courses in
South Korea and certified from Sunghuwan co Ltd for using and working of beauty technology, RF
I am director of fatty liver and related metabolic disorders study among Iranian families since 2015
and currently publishing the results of our study and research about fatty liver and hyperlipidemia,
diabetes and nutrition as study director and clinician associate member of Iran Hepatitis Network.
I am reviewer and associate editor of Hepatitis Monthly Journal and reviewer of journal of Clinical
and Translational Hepatology. I am editorial board member of International Journal of Psychology
I am certified graduate, verified reviewer and certified mentor of Publons academy in the field of
Clinical Medicine and Hepatology.
I am working clinically on patients with Brain Tumor and publishing my results on these topics:
1. Recurrent Meningioma
2. Trigeminal neuralgia
3. Radiation induced meningioma
4. Behavioral change in Brain Tumors
5. DVT prevalence and management among patients with meningioma
And some others.
I published reviews for articles on Brain Tumor Immunotherapy, CNS Tumor Guideline and Alzheimer
disease in Elsevier and Kudos. My review on Alzheimer's disease article with specific DOI, was
published in American Physiological Society.
I have been invited by editor in chief of American Journal of Translational Medicine, to participate at
International Conference of Translational Medicine, in Hawaii.
My article entitled "Trigeminal Neuralgia caused by Brain Meningioma" has been accepted for oral
presentation in world neurology and Neurodisorders Conference, Tokyo as keynote speaker.
My article in the field of neuroscience about 'Recurrent Meningioma', etiologies and clinical
aspects and tumor cellular pathology has been accepted for oral, poster presentation in World CNS
Conference, France 2018.
I am speaker of World Congress on Epilepsy in London.
I am speaker of International conference on Central Nervous System and Therapeutics for my
accepted article about recurrent Brain meningioma, in Paris 2018.
I am speaker of Annual Congress on Neurology and Neuroscience (EuroNeurology 2019) for my
accepted article on Brain stroke and meningioma held in paris,2019.
My article on trigeminal neuralgia secondary to Brain tumor was accepted for oral presentation inWorld Brain Congress in Dubai,2018 as Honorable speaker.
My article on pulmonary physiotherapy and rehabilitation related to Brain tumor surgery was
accepted for oral presentation in 6th World Congress on Physiotherapy and Rehabilitation held in
One of my works on diabetes and fatty liver as a scientific article has been accepted in 4th
International Conference on Diabetes and Its Treatments at Dubai 2018 for oral presentation and
publication and another one is about fatty liver and metabolism has been accepted for oral and
poster presentation in International Conference of Gastroenterology and Hepatology, Thailand 2018
as Honorable speaker.
I am speaker of International Conference on Obesity and Chronic diseases, 2018 in Dubai.
My article on fatty liver and vascular disorders was accepted for oral presentation in 6th World
Congress on Hypertension and Public Health in France, 2018.
I am as well, Organizing Committee Member in International Conference of Obesity and Diet
Imbalance in Indonesia, 2018 with accepted article on nutrition and fatty liver for oral presentation.
My article on vascular disorders and ischemic heart disease was accepted for oral presentation in
Global Congress on Cardiology and Interventional Cardiology held in Dubai, 2019.
I am speaker of 7th International Conference on Hypertension and Healthcare in Finland, 2019, for
my accepted article on vascular disorders related to fatty liver.
I am invited Organizing Committee Member in 3rd International Conference on Alzheimer's Disease
and Dementia held in London,2019.
As distinguished speaker, my article has been accepted for oral presentation in 22th International
Conference on New Horizons in Cardiology and Cardiologist Education held in Berlin, Germany 2019.
I am speaker of 12th International Conference on Osteoporosis, Arthritis and Musculoskeletal
disorders in London 2019, for my accepted article about discopathy secondary to brucellosis.
I am speaker and Organizing Committee Member of 6th International Conference on Rare Disease
and Orphan Drug 2019 in Dubai, for my accepted article about rare type of peptic ulcer.
My article on psoriasis related to fatty liver was accepted for oral presentation in International
Dermatology Conference: Skin and Body, held in Indonesia, 2018 as distinguished speaker.
I am Organizing Committee Member of Annual Conference on Neurology and Neuroscience
(EuroNeurology 2019) held in France.
I am Organizing Committee Member (OCM) of pulsus group conferences in the field of Heart and
- OCM of 5th International conference on vascular Biology and Surgeons Meeting London,
- OCM of 2nd Global Heart congress, Osaka, Japan, 2019.
- OCM of Global Congress on cardiology and International cardiology, Dubai, 2019.
As well, I received organizing committee membership of 15th International conference on
Metabolomics and systems Biology Japan. I am organizing committee member of World Congress on
cancer science and therapy Rome, Italy.
I am organizing committee member of world highest rank conferences in the field of neuroscience:
- OCM of Global Experts Meeting on Advances in neurology and neuropsychiatry, Melbourne,
- OCM of European Neurology congress Venice, Italy, 2019.
- OCM of International conference on Addictive Disorders and Alcoholism, Brisbane, 2019.
- OCM of 5th Global Experts Meeting on Parkinsons, Huntington's and Movement disorders,
Japan. With honor I received Organizing Committee membership of 4th World congress on
pediatric Neurology and pediatric surgery, Auckland. In the field of Neuroscience, I am
Organizing committee member of 4th Annual conference on Brain Disorders, Neurology and
Therapeutics, Spain.In scientific federation on Neuroscience, I achieved organizing committee membership of multiple
- OCM of 30th Edition of International conference on Neurology and Neuroscience, Singapore
and OCM of Alzheimer's and parkinsons conference, France, 2019.
I am distinguished speaker and organizing committee member of 12th International conference on
Osteoporosis, Arthritis and Musculoskeletal Disorders, London. As well, I am organizing committee
member of International conference on Central nervous System and Neurological Surgeons, London,
Dr. Madhusudhan, Davangere University, holds M.Sc. and PhD in Biochemistry from University of Mysore-Central Food Technological Research Institute, India. He has served the University of Mysore during 1982 and 1998 as Sr. Lecturer in Chemistry on permanent basis. While in staying in abroad (1996 - 2004), he has worked as Postdoctoral Scientist with Prof. Vic Morris, Institute of Food Research, Norwich, UK; as Research Associate with Prof. Paul Seib, Kansas State University, Manhattan, Kansas, USA; Sr. Research Associate with Prof. Dennis Wiesenborn at the North Dakota State University, Fargo, USA; Visiting Scientist with Prof. DC Gowda at the Penn State University College of Medicine, Hershey, USA, and with Prof Paul Rope at the Georgetown University Medical Center, Washington D.C, USA.
Dr. Madhusudhan is a well published researcher, who has over 32 years experience in teaching Biochemistry, Food Technology and Food Nanotechnology. Presently, he is the Chairman of the Food Technology Dept. at Davangere University, DAVANAGERE, India. He is instrumental in introducing MSc Food Technology and founder of Research Center for Nanoscience and Technology. He is professional member of several national and international societies.
He has several research Grants funded by DBT, DST (SERB), UGC and VGST (Level I and II). Dr. Madhusudhan has been awarded with cash prize and citations and being invited to deliver lectures and chair conferences/seminars/workshops both home and abroad. He has been Independent Expert and Proposal reviewer at the, European Commission, Brussels, Belgium. He was invited to speak in several European countries, Australia and Malaysia. He was the Chair to run Nanotechnology Conference 2012 held in Mexico during 31 Oct - 4 Nov 2012 and a member of the scientific committee for ICNFA’12 (http://icnfa2012.international-aset.com/committee). Currently, Dr. Madhusudhan is engaged in working on therapeutic applications of novel nutraceuticals and their nanoformulations in cancer therapy, prevention of malaria and anaplasmosis. His research is primarily focused on host immune responses and application of biodegradable polymeric nanoparticles in vivo targeted delivery, the pathways of cellular uptake of nanoparticles and sorting mechanisms in different cellular compartments.